Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
We greatly appreciate Dr. Stummer’s and Dr. Thomas’s interest in our study and their important comments [...]
Guardado en:
Autores principales: | Arthur Hosmann, Matthias Millesi, Lisa I. Wadiura, Barbara Kiesel, Petra A. Mercea, Mario Mischkulnig, Martin Borkovec, Julia Furtner, Thomas Roetzer, Stefan Wolfsberger, Joanna J. Phillips, Anna S. Berghoff, Shawn Hervey-Jumper, Mitchel S. Berger, Georg Widhalm |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d9d8a72da7e42ca955ce794633a79d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comment on Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540
por: Walter Stummer, et al.
Publicado: (2021) -
Graded I-second submodules
por: Bataineh Malik, et al.
Publicado: (2021) -
Macroscopic fluorescence-lifetime imaging of NADH and protoporphyrin IX improves the detection and grading of 5-aminolevulinic acid-stained brain tumors
por: Mikael T. Erkkilä, et al.
Publicado: (2020) -
Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma
por: Woo Hee Choi, et al.
Publicado: (2020) -
<i>TP53</i> Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy
por: Humaira Noor, et al.
Publicado: (2021)